https://www.thehindubusinessline.com/markets/caplin-point-labs-subsidiary-gets-usfda-approval-for-ofloxacin-otic-solution-03/article67718608.ece Copy Caplin Point ...
BUFFALO GROVE, Ill. -- Akorn today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Akorn’s Abbreviated New Drug Application (ANDA) for Ofloxacin Ophthalmic ...
BUFFALO GROVE, Ill. — Akorn's abbreviated new drug application for ofloxacin ophthalmic solution 0.3% has been approved by the U.S. Food and Drug Administration, the company announced in a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback